rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
1991-9-11
|
pubmed:abstractText |
Recently it has been demonstrated that the CD14 molecule which is expressed on monocytes and macrophages serves as a receptor for lipopolysaccharide (LPS) bound to LPS-binding protein (LBP) and thus mediates LPS-induced tumour necrosis factor (TNF) production. Here we report that CD14 is found as a soluble (s) molecule in serum. In healthy volunteers sCD14 levels (mean +/- s.e.m.) were 3.7 +/- 0.05 micrograms/ml (n = 30, 25-50 years of age) as determined by ELISA (detection limit 20 ng/ml serum) using two monoclonal antibodies in a sandwich technique. In polytraumatized patients (n = 16) significantly decreased levels (1.7 +/- 0.3) were detected immediately after the trauma, which increased to 4.9 +/- 0.3 micrograms/ml within the first 6 days post trauma. sCD14 remained elevated during the first 14 days post trauma in patients with the most severe injuries (injury severity score greater than 45 points), whereas a return to normal levels was observed in patients with an injury score of less than 45 points. In addition, the levels of the high-density lipoproteins that partially inactivate free endotoxin are significantly decreased post trauma. No correlation between parameters of inflammation (C3a and neopterin levels, leucocyte counts, amount of band cells), liver function and sCD14 levels was established. Comparable to polytraumatized patients, increased sCD14 serum levels were observed in five patients with burn trauma (burned area greater than 35%) within the second week post trauma when clinical signs of septicaemia were evident.
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/1713813-1095497,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1713813-1689668,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1713813-1698311,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1713813-2154525,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1713813-2199284,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1713813-2258972,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1713813-227936,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1713813-2297191,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1713813-2402637,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1713813-2412965,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1713813-2468604,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1713813-2471708,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1713813-2540344,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1713813-2540776,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1713813-2569162,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1713813-2835680,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1713813-3255346,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1713813-3290526,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1713813-3384955,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1713813-3493149,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1713813-3542580,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1713813-3555304,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1713813-4027746,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1713813-4814394
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0009-9104
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
85
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
297-301
|
pubmed:dateRevised |
2009-11-18
|
pubmed:meshHeading |
pubmed-meshheading:1713813-Adolescent,
pubmed-meshheading:1713813-Adult,
pubmed-meshheading:1713813-Aged,
pubmed-meshheading:1713813-Antigens, CD,
pubmed-meshheading:1713813-Antigens, CD14,
pubmed-meshheading:1713813-Antigens, Differentiation, Myelomonocytic,
pubmed-meshheading:1713813-Burns,
pubmed-meshheading:1713813-Female,
pubmed-meshheading:1713813-Humans,
pubmed-meshheading:1713813-Lipopolysaccharides,
pubmed-meshheading:1713813-Male,
pubmed-meshheading:1713813-Middle Aged,
pubmed-meshheading:1713813-Multiple Trauma
|
pubmed:year |
1991
|
pubmed:articleTitle |
Serum CD14 levels in polytraumatized and severely burned patients.
|
pubmed:affiliation |
Ruhr University, Bochum, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|